USD10
FHTX Shares
About Foghorn TherapeuticsFoghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
USD10
FHTX Shares
About Foghorn TherapeuticsFoghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$289.39M
OPEN PRICE
$4.75
LOW (1Y)
$3.00
HIGH (1Y)
$6.95
LOW (24H)
$4.70
HIGH (24H)
$5.03
VOLUME (24H)
$87.68K
1.65%
Price history
Time | Price | Change |
|---|---|---|
Today | $4.75 | |
1 Day | $4.93 | 0.00% |
1 Week | $4.49 | |
1 Month | $5.76 | |
1 Year | $3.68 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
